Loading...

RedHill Biopharma Ltd.

RDHL•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$1.02
$-0.01(-0.97%)
U.S. Market opens in 7h 12m

RedHill Biopharma Ltd. (RDHL) Stock Overview

Explore RedHill Biopharma Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap3.4M
P/E Ratio-0.28
EPS (TTM)$-302.63
ROE1.49%
Fundamental Analysis

AI Price Forecasts

1 Month$0.78
3 Months$0.00
1 Year Target$0.00

RDHL Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of RedHill Biopharma Ltd. (RDHL) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 70.63, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.28 and a market capitalization of 3.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.49%
5-Day Change
23.35%
1-Month Change
15.74%
3-Month Change
-24.26%
6-Month Change
-37.20%
Year-to-Date (YTD) Change
N/A
1-Year Change
-55.60%
3-Year Change
-98.46%
5-Year Change
-99.99%
All-Time (Max) Change
-99.99%

Contact Information

https://www.redhillbio.com
972 3 541 3131
21 Ha’arba’a Street, Tel Aviv, NaN, 6473921

Company Facts

35 Employees
IPO DateJan 7, 2013
CountryIL
Actively Trading

Frequently Asked Questions